Cargando…
Genomics of Post-Prandial Lipidomic Phenotypes in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
BACKGROUND: Increased postprandial lipid (PPL) response to dietary fat intake is a heritable risk factor for cardiovascular disease (CVD). Variability in postprandial lipids results from the complex interplay of dietary and genetic factors. We hypothesized that detailed lipid profiles (eg, sterols a...
Autores principales: | Irvin, Marguerite R., Zhi, Degui, Aslibekyan, Stella, Claas, Steven A., Absher, Devin M., Ordovas, Jose M., Tiwari, Hemant K., Watkins, Steve, Arnett, Donna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048279/ https://www.ncbi.nlm.nih.gov/pubmed/24905834 http://dx.doi.org/10.1371/journal.pone.0099509 |
Ejemplares similares
-
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study
por: Irvin, Marguerite R., et al.
Publicado: (2018) -
Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015) -
Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study
por: Das, Mithun, et al.
Publicado: (2016) -
Age and sex are associated with the plasma lipidome: findings from the GOLDN study
por: Slade, Emily, et al.
Publicado: (2021) -
Epigenome-Wide Association Study of Fasting Measures of Glucose, Insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study
por: Hidalgo, Bertha, et al.
Publicado: (2014)